scPharmaceuticals Inc. (SCPH) Tops Q4 EPS by 7c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q4 EPS of ($0.35), $0.07 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $5.47 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Knight Transportation (KNX) PT Raised to $85 at Stifel Ahead of Q2 Earnings
• JPMorgan Starts Shinsegae Inc (004170:KS) at Overweight